Patent Term Extension Application for ANKTIVA® (nogapendekin alfa inbakicept-pmln), Patent No. 10,150,805
🏛 Food and Drug Administration (FDA)FDA-2024-E-4130
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.